AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
RECOGNITION OF MELANOMA-DERIVED ANTIGENS BY CTL - POSSIBLE MECHANISMSINVOLVED IN DOWN-REGULATING ANTITUMOR T-CELL REACTIVITY
Authors: RIVOLTINI L LOFTUS DJ SQUARCINA P CASTELLI C RINI F ARIENTI F BELLI F MARINCOLA FM GEISLER C BORSATTI A APPELLA E PARMIANI G
Citation: L. Rivoltini et al., RECOGNITION OF MELANOMA-DERIVED ANTIGENS BY CTL - POSSIBLE MECHANISMSINVOLVED IN DOWN-REGULATING ANTITUMOR T-CELL REACTIVITY, Critical reviews in immunology, 18(1-2), 1998, pp. 55-63
BETA-2-MICROGLOBULIN MUTATIONS, HLA CLASS-I ANTIGEN LOSS, AND TUMOR PROGRESSION IN MELANOMA
Authors: HICKLIN DJ WANG ZG ARIENTI F RIVOLTINI L PARMIANI G FERRONE S
Citation: Dj. Hicklin et al., BETA-2-MICROGLOBULIN MUTATIONS, HLA CLASS-I ANTIGEN LOSS, AND TUMOR PROGRESSION IN MELANOMA, The Journal of clinical investigation, 101(12), 1998, pp. 2720-2729
INDUCTION AND FUNCTIONAL-CHARACTERIZATION OF BETA-2-MICROGLOBULIN (BETA(2)-MU)-FREE HLA CLASS-I HEAVY-CHAINS EXPRESSED BY BETA(2)-MU-DEFICIENT HUMAN FO-1 MELANOMA-CELLS
Authors: WANG ZG ARIENTI F PARMIANI G FERRONE S
Citation: Zg. Wang et al., INDUCTION AND FUNCTIONAL-CHARACTERIZATION OF BETA-2-MICROGLOBULIN (BETA(2)-MU)-FREE HLA CLASS-I HEAVY-CHAINS EXPRESSED BY BETA(2)-MU-DEFICIENT HUMAN FO-1 MELANOMA-CELLS, European Journal of Immunology, 28(9), 1998, pp. 2817-2826
ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSDUCED OR IL-4-TRANSDUCED ALLOGENEIC MELANOMA-CELLS
Authors: ARIENTI F BELLI F MAZZOCCHI A GALLINO F NAPOLITANO F MELANI C COLOMBO MP RIVOLTINI L MAIO M PARMIANI G
Citation: F. Arienti et al., ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSDUCED OR IL-4-TRANSDUCED ALLOGENEIC MELANOMA-CELLS, European journal of cancer, 33, 1997, pp. 1303-1303
T-CELL RECOGNITION OF MELANOMA-DERIVED ANTIGENS - IMPLICATION FOR PEPTIDE-BASED IMMUNOTHERAPY
Authors: RIVOLTINI L MAZZOCCHI A SQUARCINA P ARIENTI F BELLI F CASTELLI C MARINCOLA FM LOFTUS DJ PARMIANI G
Citation: L. Rivoltini et al., T-CELL RECOGNITION OF MELANOMA-DERIVED ANTIGENS - IMPLICATION FOR PEPTIDE-BASED IMMUNOTHERAPY, European journal of cancer, 33, 1997, pp. 1313-1313
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS
Authors: BELLI F MASCHERONI L GALLINO G LENISA L ARIENTI F PARMIANI G CASCINELLI N
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS, Cancer gene therapy, 4(5), 1997, pp. 334-334
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997)
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANTANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997), Cancer immunology and immunotherapy, 45(2), 1997, pp. 119-119
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY, Cancer immunology and immunotherapy, 44(4), 1997, pp. 197-203
COMPARISON OF 3 DIFFERENT METHODS FOR RADIOLABELING HUMAN ACTIVATED T-LYMPHOCYTES
Authors: BOTTI C NEGRI DRM SEREGNI E RAMAKRISHNA V ARIENTI F MAFFIOLI L LOMBARDO C BOGNI A PASCALI C CRIPPA F MASSARON S REMONTI F NERINIMOLTENI S CANEVARI S BOMBARDIERI E
Citation: C. Botti et al., COMPARISON OF 3 DIFFERENT METHODS FOR RADIOLABELING HUMAN ACTIVATED T-LYMPHOCYTES, European journal of nuclear medicine, 24(5), 1997, pp. 497-504
DIFFERENCES IN FREQUENCY-DISTRIBUTION OF HLA-A2 SUBTYPES BETWEEN NORTH-AMERICAN AND ITALIAN WHITE MELANOMA PATIENTS - RELEVANCE FOR EPITOPE-SPECIFIC VACCINATION PROTOCOLS
Authors: PLAYER MA BARRACCHINI KC SIMONIS TB RIVOLTINI L ARIENTI F CASTELLI C MAZZOCCHI A BELLI F PARMIANI G MARINCOLA FM
Citation: Ma. Player et al., DIFFERENCES IN FREQUENCY-DISTRIBUTION OF HLA-A2 SUBTYPES BETWEEN NORTH-AMERICAN AND ITALIAN WHITE MELANOMA PATIENTS - RELEVANCE FOR EPITOPE-SPECIFIC VACCINATION PROTOCOLS, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 357-363
LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS
Authors: ARIENTI F SULESUSO J BELLI F MASCHERONI L RIVOLTINI L MELANI C MAIO M CASCINELLI N COLOMBO MP PARMIANI G
Citation: F. Arienti et al., LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS, Human gene therapy, 7(16), 1996, pp. 1955-1963
BINDING, PRESENTATION AND IMMUNOGENICITY OF PEPTIDES DERIVED FROM MELANOMA ANTIGENS MART-1 AND GP100 BY HLA-A2 SUBTYPES
Authors: RIVOLTINI L LOFTUS DJ BARRACCHINI K ARIENTI F MAZZOCCHI A SQUARCINA P BIDDISON WE APPELLA E PARMIANI G MARINCOLA FM
Citation: L. Rivoltini et al., BINDING, PRESENTATION AND IMMUNOGENICITY OF PEPTIDES DERIVED FROM MELANOMA ANTIGENS MART-1 AND GP100 BY HLA-A2 SUBTYPES, The FASEB journal, 10(6), 1996, pp. 2706-2706
BINDING AND PRESENTATION OF PEPTIDES DERIVED FROM MELANOMA ANTIGENS MART-1 AND GLYCOPROTEIN-100 BY HLA-A2 SUBTYPES - IMPLICATIONS FOR PEPTIDE-BASED IMMUNOTHERAPY
Authors: RIVOLTINI L LOFTUS DJ BARRACCHINI K ARIENTI F MAZZOCCHI A BIDDISON WE SALGALLER ML APPELLA E PARMIANI G MARINCOLA FM
Citation: L. Rivoltini et al., BINDING AND PRESENTATION OF PEPTIDES DERIVED FROM MELANOMA ANTIGENS MART-1 AND GLYCOPROTEIN-100 BY HLA-A2 SUBTYPES - IMPLICATIONS FOR PEPTIDE-BASED IMMUNOTHERAPY, The Journal of immunology, 156(10), 1996, pp. 3882-3891
CYTOKINE-BASED GENE-THERAPY OF HUMAN TUMORS - AN OVERVIEW
Authors: PARMIANI G ARIENTI F SULESUSO J MELANI C COLOMBO MP RAMAKRISHNA V BELLI F MASCHERONI L RIVOLTINI L CASCINELLI N
Citation: G. Parmiani et al., CYTOKINE-BASED GENE-THERAPY OF HUMAN TUMORS - AN OVERVIEW, Folia biologica, 42(6), 1996, pp. 305-309
REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY
Authors: CANEVARI S STOTER G ARIENTI F BOLIS G COLNAGHI MI DIRE EM EGGERMONT AMM GOEY SH GRATAMA JW LAMERS CHJ NOOY MA PARMIANI G RASPAGLIESI F RAVAGNANI F SCARFONE G TRIMBOS JB WARNAAR SO BOLHUIS RLH
Citation: S. Canevari et al., REGRESSION OF ADVANCED OVARIAN-CARCINOMA BY INTRAPERITONEAL TREATMENTWITH AUTOLOGOUS T-LYMPHOCYTES RETARGETED BY A BISPECIFIC MONOCLONAL-ANTIBODY, Journal of the National Cancer Institute, 87(19), 1995, pp. 1463-1469
ISOLATION PERFUSION IN EXTRACORPOREAL-CIRCULATION WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF IN-TRANSIT METASTASES FROM LIMB CUTANEOUS MELANOMA
Authors: VAGLINI M BELLI F SANTINAMI M ARIENTI F PARMIANI G PERSIANI L SANTORO N INGLESE MG DELIA F CASCINELLI N
Citation: M. Vaglini et al., ISOLATION PERFUSION IN EXTRACORPOREAL-CIRCULATION WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF IN-TRANSIT METASTASES FROM LIMB CUTANEOUS MELANOMA, Annals of surgical oncology, 2(1), 1995, pp. 61-70
A HUMAN-MELANOMA CELL-LINE TRANSDUCED WITH AN INTERLEUKIN-4 GENE BY ARETROVIRAL VECTOR RELEASES BIOLOGICALLY-ACTIVE IL-4 AND MAINTAINS THEORIGINAL TUMOR ANTIGENIC PHENOTYPE
Authors: MELANI C SULESUSO J ARIENTI F MACCALLI C PASSERINI F COLOMBO MP PARMIANI G
Citation: C. Melani et al., A HUMAN-MELANOMA CELL-LINE TRANSDUCED WITH AN INTERLEUKIN-4 GENE BY ARETROVIRAL VECTOR RELEASES BIOLOGICALLY-ACTIVE IL-4 AND MAINTAINS THEORIGINAL TUMOR ANTIGENIC PHENOTYPE, Human gene therapy, 6(11), 1995, pp. 1427-1436
CLINICAL-RESULTS OF A NEW APPROACH OF THERAPY OF OVARIAN-CANCER - RETARGETING OF T-CELL CYTOTOXICITY BY BISPECIFIC ANTIBODIES
Authors: CANEVARI S MAZZONI A NEGRI DRM ARIENTI F RAMAKRISHNA V BOLHUIS R BOLIS G COLNAGHI MI
Citation: S. Canevari et al., CLINICAL-RESULTS OF A NEW APPROACH OF THERAPY OF OVARIAN-CANCER - RETARGETING OF T-CELL CYTOTOXICITY BY BISPECIFIC ANTIBODIES, European journal of cancer, 31A, 1995, pp. 493-493
ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSFECTED ALLOGENEIC MELANOMA-CELLS - A PHASE I-II STUDY
Authors: ARIENTI F BELLI F SULESUSO J MAIO M MASCHERONI L MELANI C
Citation: F. Arienti et al., ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSFECTED ALLOGENEIC MELANOMA-CELLS - A PHASE I-II STUDY, European journal of cancer, 31A, 1995, pp. 997-997
PRELIMINARY CLINICAL-RESULTS OF ACTIVE IMMUNIZATION WITH INTERLEUKIN-4 GENE TRANSFECTED ALLOGENEIC MELANOMA-CELLS IN METASTATIC MELANOMA PATIENTS
Authors: BELLI F ARIENTI F MASCHERONI L SULESUSO J ILLENI MT MARCHIANO A PARMIANI G CASCINELLI N
Citation: F. Belli et al., PRELIMINARY CLINICAL-RESULTS OF ACTIVE IMMUNIZATION WITH INTERLEUKIN-4 GENE TRANSFECTED ALLOGENEIC MELANOMA-CELLS IN METASTATIC MELANOMA PATIENTS, European journal of cancer, 31A, 1995, pp. 1275-1275
TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3
Authors: MARCHAND M WEYNANTS P RANKIN E ARIENTI F BELLI F PARMIANI G CASCINELLI N BOURLOND A VANWIJCK R HUMBLET Y CANON JL LAURENT C NAEYAERT JM PLAGNE R DERAEMAEKER R KNUTH A JAGER E BRASSEUR F HERMAN J COULIE PG BOON T
Citation: M. Marchand et al., TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3, International journal of cancer, 63(6), 1995, pp. 883-885
EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA
Authors: BRASSEUR F RIMOLDI D LIENARD D LETHE B CARREL S ARIENTI F SUTER L VANWIJCK R BOURLOND A HUMBLET Y VACCA A CONESE M LAHAYE T DEGIOVANNI G DERAEMAECKER R BEAUDUIN M SASTRE X SALAMON E DRENO B JAGER E KNUTH A CHEVREAU C SUCIU S LACHAPELLE JM POUILLART P PARMIANI G LEJEUNE F CEROTTINI JC BOON T MARCHAND M
Citation: F. Brasseur et al., EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA, International journal of cancer, 63(3), 1995, pp. 375-380
A B7-1-TRANSFECTED HUMAN-MELANOMA LINE STIMULATES PROLIFERATION AND CYTOTOXICITY OF AUTOLOGOUS AND ALLOGENEIC LYMPHOCYTES
Authors: SULESUSO J ARIENTI F MELANI C COLOMBO MP PARMIANI G
Citation: J. Sulesuso et al., A B7-1-TRANSFECTED HUMAN-MELANOMA LINE STIMULATES PROLIFERATION AND CYTOTOXICITY OF AUTOLOGOUS AND ALLOGENEIC LYMPHOCYTES, European Journal of Immunology, 25(10), 1995, pp. 2737-2742
OVEREXPRESSION OF THE T-CELL RECEPTOR BETA-CHAIN VARIABLE REGION TCRBV14 IN HLA-A2-MATCHED PRIMARY HUMAN MELANOMAS
Authors: SALVI S SEGALLA F RAO S ARIENTI F SARTORI M BRATINA G CARONNI E ANICHINI A CLEMENTE C PARMIANI G SENSI M
Citation: S. Salvi et al., OVEREXPRESSION OF THE T-CELL RECEPTOR BETA-CHAIN VARIABLE REGION TCRBV14 IN HLA-A2-MATCHED PRIMARY HUMAN MELANOMAS, Cancer research, 55(15), 1995, pp. 3374-3379
INTERLEUKIN-2 GENE-TRANSDUCED HUMAN-MELANOMA CELLS EFFICIENTLY STIMULATE MHC-UNRESTRICTED AND MHC-RESTRICTED AUTOLOGOUS LYMPHOCYTES
Authors: ARIENTI F SULESUSO J MELANI C MACCALLI C BELLI F ILLENI MT ANICHINI A CASCINELLI N COLOMBO MP PARMIANI G
Citation: F. Arienti et al., INTERLEUKIN-2 GENE-TRANSDUCED HUMAN-MELANOMA CELLS EFFICIENTLY STIMULATE MHC-UNRESTRICTED AND MHC-RESTRICTED AUTOLOGOUS LYMPHOCYTES, Human gene therapy, 5(9), 1994, pp. 1139-1150
Risultati: 1-25 | 26-27